Targeting Plasma Membrane Ca2+-ATPases in Cancer: Current Insights and Future Perspectives
Malwina Lisek, Julia Tomczak, Natalia Bochenska, Julia Duraj, Tomasz Boczek · 2026
Read Targeting Plasma Membrane Ca2+-ATPases in Cancer: Current Insights and Future Perspectives by Malwina Lisek, Julia Tomczak, Natalia Bochenska, Julia Duraj, Tomasz Boczek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13464777.txt.
Description
Lisek and co-authors review the calcium pumps that cancers exploit, isoform by isoform. Their 2026 paper covers the plasma membrane calcium ATPases, the pumps that expel calcium from cells and shape the local calcium microdomains where signalling decisions are made. Beyond housekeeping, these pumps assemble signalling complexes that steer proliferation, migration, invasion, cell death, and treatment resistance.
The review's central point is that the four pump variants behave differently, even oppositely, by context. Two of them, PMCA2 and PMCA4, regulate oncogenic signalling through compartmentalised calcium in several cancers, acting as promoters in some settings and suppressors in others. PMCA1 and PMCA3 play narrower, specialised roles in selected malignancies. The authors summarise each isoform's structure, regulation, and tumour contributions, and assess the family's promise as prognostic biomarkers and precision drug targets.
Catalog record
| CREATOR | Malwina Lisek, Julia Tomczak, Natalia Bochenska, Julia Duraj, Tomasz Boczek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |